| |
| |
|
| Insider
Information: |
Freitag Gregory Gene |
| Relationship: |
|
| City: |
Texarkana |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
364,795 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,590,340 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
364,795 |
|
|
| Total
Value |
$1,590,340 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -15.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pressure Biosciences Inc |
PBIO |
Director |
2012-04-05 |
47,048 |
|
0 |
Premium* |
|
|
Axogen Inc |
AXGN |
Director |
2024-03-07 |
271,594 |
2011-11-21 |
0 |
Premium* |
|
|
PDS Biotechnology Corp |
PDSB |
|
2021-06-15 |
46,153 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PBIO |
Pressure Biosciences Inc |
Director |
– • – |
2010-07-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
216 |
|
- |
|
| PDSB |
PDS Biotechnology Corp |
|
– • – |
2019-03-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,871 |
|
- |
|
| AXGN |
Axogen Inc |
CFO |
• • – |
2011-11-21 |
4 |
B |
$2.86 |
$17,395 |
D/D |
6,000 |
6,000 |
2.81 |
- |
|
| AXGN |
Axogen Inc |
CFO |
• • – |
2011-11-22 |
4 |
B |
$2.87 |
$26,250 |
D/D |
9,000 |
15,000 |
2.81 |
- |
|
| PBIO |
Pressure Biosciences Inc |
Director |
– • – |
2011-09-02 |
4 |
A |
$0.00 |
$0 |
D/D |
14,880 |
16,023 |
0 |
- |
|
| AXGN |
Axogen Inc |
CFO |
• • – |
2014-06-02 |
4 |
B |
$2.45 |
$12,250 |
D/D |
5,000 |
29,318 |
2.81 |
- |
|
| AXGN |
Axogen Inc |
CFO |
• • – |
2014-06-03 |
4 |
B |
$2.34 |
$468 |
D/D |
200 |
29,518 |
2.73 |
- |
|
| AXGN |
Axogen Inc |
CFO |
• • – |
2013-08-14 |
4 |
B |
$3.00 |
$25,002 |
D/D |
8,334 |
32,652 |
2.81 |
- |
|
| AXGN |
Axogen Inc |
CFO |
• • – |
2014-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
38,901 |
0 |
- |
|
| PDSB |
PDS Biotechnology Corp |
|
• • – |
2020-02-14 |
4 |
A |
$1.30 |
$49,920 |
D/D |
38,400 |
40,271 |
0 |
- |
|
| PBIO |
Pressure Biosciences Inc |
Director |
– • – |
2011-09-30 |
4 |
OE |
$1.88 |
$50,083 |
D/D |
26,640 |
42,663 |
0 |
- |
|
| PDSB |
PDS Biotechnology Corp |
|
• • – |
2021-06-15 |
4 |
B |
$8.50 |
$49,997 |
D/D |
5,882 |
46,153 |
0.01 |
- |
|
| PBIO |
Pressure Biosciences Inc |
Director |
– • – |
2012-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,385 |
47,048 |
0 |
- |
|
| AXGN |
Axogen Inc |
General Counsel |
• • – |
2015-02-10 |
4 |
A |
$2.75 |
$13,200 |
D/D |
4,800 |
48,902 |
0 |
- |
|
| AXGN |
Axogen Inc |
General Counsel & SVP BD |
• • – |
2016-12-30 |
4 |
OE |
$2.74 |
$63,020 |
D/D |
23,000 |
71,901 |
0 |
- |
|
| AXGN |
Axogen Inc |
General Counsel & SVP BD |
• • – |
2017-08-27 |
4 |
D |
$16.65 |
$63,020 |
D/D |
(3,785) |
91,116 |
0 |
- |
|
| AXGN |
Axogen Inc |
General Counsel & SVP BD |
• • – |
2017-08-27 |
4 |
OE |
$2.74 |
$63,020 |
D/D |
23,000 |
94,901 |
0 |
- |
|
| AXGN |
Axogen Inc |
General Counsel |
• • – |
2018-11-30 |
4 |
AS |
$33.00 |
$1,485,000 |
D/D |
(45,000) |
95,865 |
0 |
- |
|
| AXGN |
Axogen Inc |
General Counsel & SVP BD |
• • – |
2017-09-25 |
4 |
D |
$18.90 |
$27,405 |
D/D |
(1,450) |
99,666 |
0 |
- |
|
| AXGN |
Axogen Inc |
General Counsel |
• • – |
2019-02-15 |
4 |
A |
$17.57 |
$59,334 |
D/D |
3,377 |
100,260 |
0 |
- |
|
| AXGN |
Axogen Inc |
General Counsel & SVP BD |
• • – |
2017-09-25 |
4 |
OE |
$2.74 |
$27,400 |
D/D |
10,000 |
101,116 |
0 |
- |
|
| AXGN |
Axogen Inc |
General Counsel |
• • – |
2019-12-18 |
4 |
D |
$16.73 |
$9,486 |
D/D |
(567) |
101,543 |
0 |
- |
|
| AXGN |
Axogen Inc |
General Counsel |
• • – |
2019-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,850 |
102,110 |
0 |
- |
|
| AXGN |
Axogen Inc |
General Counsel |
• • – |
2020-02-18 |
4 |
D |
$14.68 |
$22,475 |
D/D |
(1,531) |
106,484 |
0 |
- |
|
| AXGN |
Axogen Inc |
General Counsel |
• • – |
2020-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
5,160 |
107,013 |
0 |
- |
|
54 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
